Novel aromatase inhibitor, ODM-201, may be safe and effective for prostate cancer
1. In a phase I trial, ODM-201 was well tolerated up to 1800mg per day in prostate cancer patients, without ...
1. In a phase I trial, ODM-201 was well tolerated up to 1800mg per day in prostate cancer patients, without ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.